Monthly Newsletter

Oxford Global are proud to present the 2nd Annual Cell and Gene Therapy Congress, taking place on the 3–4 November 2016, at the Radisson Blu Portman Hotel, London, UK. Our highly anticipated event will bring together key leaders in the cell and gene therapy field to discuss updates in development, clinical trials, genome editing technologies, bioprocessing and manufacturing.  

This congress will have 2 interactive streams:

• Cell & Gene Therapy: Development, Clinical Trials & Commercialisation

• Cell Therapy Bioprocessing and Manufacturing

Significant medical advances have been made which have in turn, also highlighted challenges for future cell and gene therapy research, funding limitations and the strict regulatory guidelines imposed. Thanks to recent advancements in the field, the potential that cell and gene therapies have is set to transform the future of disease treatment.

This two day conference will bring together over 250 senior level experts discussing the hottest topics, updates and challenges in the cell and gene therapy field. The conference programme consists of world-class keynote addresses, industry and academic led presentations, as well as ample 1-1 networking opportunities, creating an interactive platform for high-level scientific and business discussions. 

New for 2016 is a revamped conference programme that features a stronger focus on regulatory pathways. This is a pressing issue for the cell and gene therapy industry with a particular focus on Japanese regulatory frameworks, in comparison to US and European approaches. Delegates will have the opportunity to hear future challenges of reimbursement strategies, the transfer of cell therapies into commercial products and updates in clinical trial case studies. In addition to this, our expert speakers will discuss advances in CAR-T cell-based therapies and scale-up of manufacturing.

For further information click here